vorinostat has been researched along with B16 Melanoma in 4 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To improve the bioavailability and anticancer potential of suberoylanilide hydroxamic acid (SAHA) by developing a drug-loaded polymeric nanomicellar system." | 1.46 | Polymeric micelles of suberoylanilide hydroxamic acid to enhance the anticancer potential in vitro and in vivo. ( Biswas, S; Ghanta, P; Ghosh, B; Kiran Rompicharla, SV; Kumari, P; Trivedi, P, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, R | 1 |
| Wang, C | 2 |
| Li, Z | 2 |
| Xiao, J | 1 |
| Li, C | 1 |
| Wang, X | 1 |
| Kong, P | 1 |
| Cao, J | 1 |
| Huang, F | 1 |
| Huang, Y | 1 |
| Chen, Y | 1 |
| Li, X | 1 |
| Yang, D | 1 |
| Zhang, H | 1 |
| Mai, J | 1 |
| Feng, G | 1 |
| Deng, R | 1 |
| Zhu, X | 1 |
| Lu, F | 1 |
| Hou, L | 1 |
| Wang, S | 1 |
| Yu, Y | 1 |
| Zhang, Y | 1 |
| Sun, L | 1 |
| Ma, Z | 1 |
| Yang, F | 1 |
| Sagwal, SK | 1 |
| Pasqual-Melo, G | 1 |
| Bodnar, Y | 1 |
| Gandhirajan, RK | 1 |
| Bekeschus, S | 1 |
| Kiran Rompicharla, SV | 1 |
| Trivedi, P | 1 |
| Kumari, P | 1 |
| Ghanta, P | 1 |
| Ghosh, B | 1 |
| Biswas, S | 1 |
4 other studies available for vorinostat and B16 Melanoma
| Article | Year |
|---|---|
SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.
Topics: Animals; Antineoplastic Agents; B7-H1 Antigen; CD8-Positive T-Lymphocytes; Drug Resistance, Neoplasm | 2020 |
Lysosome activable polymeric vorinostat encapsulating PD-L1KD for a combination of HDACi and immunotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Survival; Chemistry, Pharmac | 2021 |
Combination of chemotherapy and physical plasma elicits melanoma cell death via upregulation of SLC22A16.
Topics: Animals; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Cell Death; Cell Line, Tumor | 2018 |
Polymeric micelles of suberoylanilide hydroxamic acid to enhance the anticancer potential in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Chromatography, High Pres | 2017 |